Photo gallery

More than 60 executives from companies and stakeholders that are members of CataloniaBio & HealthTech participated in the first UnConference, held on 29 November at the Sant Pere de Clarà Farmhouse in Argentona (Barcelona), to debate the future of therapeutic solutions for healthcare in Catalonia and the world. The sector currently makes up 7.2% of the Catalan GDP and companies are raising more than €100 million in investment each year.

The welcome session was hosted by Jaume Amat, president of CataloniaBio & HealthTech and CEO of Specipig, and Albert Barberà, director general for Research and Innovation in ...


Accompanied by the director general of research, Joan Gómez, the president of the Government of Catalonia, Quim Torra, visited on 30th November the company Rob Surgical in El Prat de Llobregat (Barcelona). The company designs and develops new robotic systems for minimally invasive surgery.

During the visit, the president and the director general of research attended a simulation of the Bitrack System carrying out a nephrectomy with Dr Lluís Peri of Barcelona's Hospital Clínic

"It is encouraging to see innovative companies such as Rob Surgical that are international right from the start. We hope to bring this technology to ...


Lamentem comunicar-vos la defunció sobtada de l'Àlex Casta, membre de la nostra associació i bon amic de molts de nosaltres. En nom de la junta volem expressar el més sentit condol a la seva família i amics per aquesta trista pèrdua. L'Àlex ha estat l'ànima d'UPF Ventures, un projecte empresarial en el qual tenia dipositada una gran il·lusió i estava realitzant un excel·lent treball. Anteriorment va ocupar càrrecs de responsabilitat a Caixa Capital Risc, Biocat i la Fundació Bosch i Gimpera, a més de fundar l'start-up RadisMed.

La vetlla es farà el dimarts 11 de desembre de 16 h ...


The biotechnology company Iproteos and the Institute of Bioengineering of Catalonia (IBEC), CataloniaBio & HealthTech members, and the Vall d'Hebron Research Institute (VHIR) are set to develop an innovative treatment to slow down, stop and even reverse the growth of solid tumors, which represent more than 90% of cancer cases. 

The project, which received €935,000 from the Spanish Ministry of Science, Innovation and Universities, through of the call 2017 Retos, will focus in its first phase on two of the most common solid tumors in children and adolescents, rhabdomyosarcoma and neuroblastoma, as well as in lung and colon ...


Kymos Pharma Services, a Contract Research Organisation that provides quality control and R&D services for the biopharmaceutical industry and a CataloniaBio & HealthTech member, has added Dr Montserrat Barceló to its Board of Directors as an independent external advisor. The company has therefore completed the process of gradually filling its executive bodies with professionals in order to tackle new challenges associated with international expansion.

Barceló has a degree in medicine from the University of Barcelona and a master from the ESADE Executive Programme for Women in Upper Management. She is currently director of operations at TFS and a founding partner ...